SEXUALLY TRANSMITTED DISEASE PRODUCT SALES TO TOP $2 BILLION, SPURRED BY BIOTECHNOLOGY, DEMOGRAPHICS.MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Supported by emerging bio- engineered drugs and demographic trends, U.S. sales of sexually transmitted disease sexually transmitted disease (STD) or venereal disease, term for infections acquired mainly through sexual contact. Five diseases were traditionally known as venereal diseases: gonorrhea, syphilis, and the less common granuloma inguinale, diagnostic test and therapeutic products will grow from $1.67 billion in 1993 to $2.05 billion in the year 2000 at a 3 percent compound annual rate, projects a new study just released by Frost & Sullivan. As of 1993, therapeutics accounted for 56 percent of market revenues, viral diagnostics 39 percent and bacterial diagnostics 5 percent, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the report, SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET: BIO-ENGINEERED PHARMACEUTICALS PLAY A MAJOR ROLE IN NEW PRODUCT DEVELOPMENT. While demographics The attributes of people in a particular geographic area. Used for marketing purposes, population, ethnic origins, religion, spoken language, income and age range are examples of demographic data. have caused some diseases to show reduced incidence levels in the early 1990s, many of these are projected to rebound on a demographic basis in the latter part of the decade as the population in higher-risk ages again increases. Manufacturers are increasingly using biotechnology to alter pharmaceuticals to improve their functioning. Recombinant Hepatitis B vaccines hepatitis B vaccine n. Abbr. HB A vaccine prepared from the inactivated surface antigen of the hepatitis B virus and used to immunize against hepatitis B. now available, for example, are safer than previous formulations. The new, more direct tests are able to more accurately determine the presence of disease. PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) (polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is ) diagnosis using DNA amplification DNA amplification Molecular diagnostics Any method used to ↑ the copy number of a sequence of DNA. See Cycling probe technology, Gap LCR–gap ligase chain reaction, Gene amplification, NASBA–nucleic acid sequence-based amplification, PCR, to detect diseases at an early stage has been made available for testing for clamydia and is available in Europe for HIV testing HIV test Various tests have been used to detect HIV and production of antibodies thereto; some HTs shown below are no longer actively used, but are listed for completeness and context. See HIV, Immunoblot. . If and when PCR is decisively shown to be more effective than current methods and its cost is brought down, it is likely to be the next major step in advancing testing technologies. There has not yet been sufficient testing to definitively prove its superior effectiveness to standard methods. In its present format, the test is also costly and requires great skill on the part of those administering it. DNA-based testing will increase dramatically in popularity when DNA amplification products make possible the use of urine as the serum for analysis rather than current DNA-based probe tests that require taking swabs directly from patients' genitals gen·i·tals pl.n. Genitalia. . Companies are building stronger units through strategic alliances. Firms will increasingly pool their efforts to provide the best products at the lowest price as the healthcare market requires ever-greater economies by manufacturers in their development and marketing. A fourth anti-retroviral was approved for use against HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. disease in the summer of 1994. While none of the four current major anti-HIV medications provide satisfactory results alone, some seem to provide benefits in combination with other anti-retrovirals and therapies. Frost & Sullivan is an international high-technology research firm. All Frost & Sullivan reports are based on extensive interviews with marketing and technical experts from selected companies in each market segment. Primary research is validated by thorough analysis of available secondary research. Frost & Sullivan is the leading publisher worldwide of high-technology research reports. Report: 5039-52 Publication Date: 1994 Price: $2295 Total Sexually Transmitted Disease Diagnostic Test and Therapeutic Product Market: Percent of Revenues by Type of Product (U.S.), 1990-2000 Bacterial Viral Thera Year (%) (%) (%) 1990 6.3 47.6 46.1 1991 5.8 45.1 49.0 1992 5.4 41.7 52.9 1993 5.1 38.8 56.1 1994 5.1 37.5 57.4 1995 5.2 36.8 58.0 1996 5.3 36.4 58.3 1997 5.4 36.1 58.5 1998 5.4 37.1 57.6 1999 5.4 37.0 57.6 2000 5.4 37.1 57.5 CONTACT: For further information please contact: Amy Arnell Kristina Menzefricke Nadge Keryhuel Mountain View London Paris (415) 961-9000 44 171 730 3438 33 1 4742 9127 (415) 961-5042(fax) 44 171 730 3343 33 1 4742 9129 REPEATS: New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of 212-575-8822 or 800-221-2462; Boston 617-330-5311 or 80 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion